Archives
Role Of Obesity & Diet In Polycystic Kidney Disease (PKD) Progression
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Role Of Obesity & Diet In Polycystic Kidney Disease (PKD) Progression
Polycystic Kidney Disease (PKD) is the most commonly inherited disease that can lead to kidney failure. The role of various diets in PKD disease progression is a hot topic among researchers and clinicians. In addition, a new study established that being overweight and obese are risk factors in PKD progression.1
Please join us and our leading expert, Kristen Nowak, PhD, MPH, as she showcases her laboratory findings about the complex relationship between diet, obesity and the role that they play in disease progression.
- Nowak K et al, JASN, 2018 Feb; 29(2): 571–578
Featuring
Kristen Nowak, PhD, MPH
University of Colorado Anschutz Medical Campus, Division of Renal Diseases and Hypertension*
Kristen Nowak, PhD, MPH, is currently an Associate Professor at the University of Colorado Anschutz Medical Campus, Division of Renal Diseases and Hypertension. She received her PhD from the University of Colorado Boulder in integrative physiology and completed a postdoctoral fellowship (nephrology) and MPH (epidemiology) at the University of Colorado Anschutz Medical Campus. She has been principal investigator or co-investigator for several ongoing and completed ADPKD clinical trials. Her work is supported by funding from the National Institutes of Health and the Polycystic Kidney Disease Foundation. She is particularly focused on the role of lifestyle, including dietary interventions and weight loss, and the progression ADPKD, as well as physiological mechanisms involved. She also directs the Clinical Vascular Physiology Laboratory in the Division of Renal Diseases and Hypertension.
Hannah N. Lambert, PharmD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Hannah N. Lambert is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy and completed her clinical residency training at Xavier University of Louisiana College of Pharmacy in New Orleans, LA. Prior to joining Otsuka, Dr Lambert was a clinical pharmacist at Ochsner Health in Digital Medicine.
Sachin Hajarnis, PhD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Sachin Hajarnis, PhD is a Senior Medical Science Liaison at Otsuka Pharmaceuticals. Dr Hajarnis has a Bachelors and Masters in Life Sciences from University of Mumbai, India. He obtained a PhD in Biochemistry and Molecular Biology from Colorado State University. Dr Hajarnis joined the University of Texas Southwestern Medical school in Dallas, as a post-doctoral fellow in the department of Nephrology where he performed basic research on various aspects of Polycystic Kidney Disease (PKD). He continued his studies on the role of micro-RNAs in PKD as a Research Scientist for several years before joining his current position at Otsuka.
*Dr Kristen Nowak is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Hannah Lambert and Sachin Hajarnis are employees of OPDC.